Menu

Bridging The Gap: Advancing Multipurpose Prevention Technologies from the Lab into the Hands of Women

In “Bridging The Gap: Advancing Multipurpose Prevention Technologies from the Lab into the Hands of Women,” an open source commentary in Biology of Reproduction, PHI’s Bethany Young Holt and partners explore strategies and calls to action for bridging MPT funding and development gaps in order to advance these products to reach the hands of women. 

Multipurpose Prevention Technologies (MPTs) are a suite of products that combine prevention of at least two sexual and reproductive health (SRH) risks, including HIV, other STIs, and unintended pregnancy.

MPTs have the capacity to help women take control of their sexual health, but funding to support the development of MPTs is needed to realize its full potential.

In “Bridging The Gap: Advancing Multipurpose Prevention Technologies from the Lab into the Hands of Women,” an open source commentary in Biology of Reproduction, PHI’s Bethany Young Holt and partners explore strategies and calls to action for bridging MPT funding and development gaps in order to advance these products to reach the hands of women.

Read the commentary

Originally published by Biology of Reproduction


Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Emergency room nurse talks with patient

Close

New Study: ED Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Patients who get their first dose of buprenorphine in the Emergency Department (ED) are more likely to remain engaged in opioid use disorder treatment 30 days post-discharge, finds a new study from PHI's CA Bridge—reinforcing EDs as critical access points to highly effective, life-saving medication for addiction treatment.

read the study

Continue to PHI.org